Related references
Note: Only part of the references are listed.Contingent valuation in health care: Does it matter how the 'Good' is described?
Richard D. Smith
HEALTH ECONOMICS (2008)
Incorporation of process preferences within the QALY framework: A study of alternative methods
Paul McNamee et al.
MEDICAL DECISION MAKING (2008)
Outcome measurement in clinical genetics services: A systematic review of validated measures
Katherine Payne et al.
VALUE IN HEALTH (2008)
Can pharmacoeconomics and outcomes research contribute to the empowerment of women affected by breast cancer?
Jessica T Lee et al.
Expert Review of Pharmacoeconomics & Outcomes Research (2008)
Decision analysis using individual patient preferences to determine optimal treatment for localized prostate cancer
Benjamin D. Sommers et al.
CANCER (2007)
Outcome measures for clinical genetics services: A comparison of genetics healthcare professionals and patients' views
Katherine Payne et al.
HEALTH POLICY (2007)
Measuring patient preferences for colorectal cancer screening using a choice-format survey
Deborah A. Marshall et al.
VALUE IN HEALTH (2007)
Valuing personalized medicine: willingness to pay for genetic testing for colorectal cancer risk
Stephanie L. Van Bebber et al.
PERSONALIZED MEDICINE (2007)
Exploring preference anomalies in double bounded contingent valuation
Verity Watson et al.
JOURNAL OF HEALTH ECONOMICS (2007)
Women's preferences for cervical cancer screening:: A study using a discrete choice experiment
Sarah Wordsworth et al.
INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE (2006)
What influences participation in genetic carrier testing? Results from a discrete choice experiment
Jane Hall et al.
JOURNAL OF HEALTH ECONOMICS (2006)
Cost-effectiveness of preventive strategies for women with a BRCA1 or a BRCA2 mutation
K Anderson et al.
ANNALS OF INTERNAL MEDICINE (2006)
Genetic Health Technology and Economic Evaluation A Critical Review
James Jarrett et al.
APPLIED HEALTH ECONOMICS AND HEALTH POLICY (2006)
Changing perspectives on the benefits of newborn screening
Donald B. Bailey et al.
MENTAL RETARDATION AND DEVELOPMENTAL DISABILITIES RESEARCH REVIEWS (2006)
Genetic screening by DNA technology: A systematic review of health economic evidence
Wolf Rogowski
INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE (2006)
Using discrete choice experiments within a cost-benefit analysis framework - Some considerations
Emma McIntosh
PHARMACOECONOMICS (2006)
Economic evaluation and decision making in the UK
Martin J. Buxton
PHARMACOECONOMICS (2006)
Should Patients Have a Greater Role in Valuing Health States?
John Brazier et al.
APPLIED HEALTH ECONOMICS AND HEALTH POLICY (2005)
Economic analyses of human genetics services: A systematic review
JJ Carlson et al.
GENETICS IN MEDICINE (2005)
Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility:: Systematic evidence review for the US Preventive Services Task Force
HD Nelson et al.
ANNALS OF INTERNAL MEDICINE (2005)
How can the evaluation of genetic tests be enhanced? Lessons learned from the ACCE framework and evaluating genetic tests in the United Kingdom
S Sanderson et al.
GENETICS IN MEDICINE (2005)
Implications of spillover effects within the family for medical cost-effectiveness analysis
A Basu et al.
JOURNAL OF HEALTH ECONOMICS (2005)
Cost-effectiveness analysis of prenatal population-based fragile X carrier screening
TJ Musci et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2005)
Cost utility of prenatal diagnosis and the risk-based threshold
RA Harris et al.
LANCET (2004)
Women and health care professionals' preferences for Down's Syndrome screening tests: a conjoint analysis study
AJ Bishop et al.
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2004)
Is economic evaluation in touch with society's health values?
J Coast
BRITISH MEDICAL JOURNAL (2004)
Psychological consequences and predictors of adverse events in the first 5 years after predictive testing for Huntington's disease
EW Almqvist et al.
CLINICAL GENETICS (2003)
Prenatal cystic fibrosis screening in Mexican Americans: An economic analysis
NM Doyle et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2003)
The use of gene tests to detect hereditary predisposition to chronic disease: Is cost-effectiveness analysis relevant?
NF Col
MEDICAL DECISION MAKING (2003)
Construction of the contingent valuation market in health care: a critical assessment
RD Smith
HEALTH ECONOMICS (2003)
Valuing the benefits and costs of health care programmes: where's the 'extra' in extra-welfarism?
S Birch et al.
SOCIAL SCIENCE & MEDICINE (2003)
Cost effectiveness analysis in health care: contraindications
C Donaldson et al.
BRITISH MEDICAL JOURNAL (2002)
Genetic test evaluation: Information needs of clinicians, policy makers, and the public
W Burke et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2002)
Prenatal screening for cystic fibrosis: an economic analysis
R Nielson et al.
HEALTH ECONOMICS (2002)
Randomized, double-blind, placebo-controlled trial of recombinant human erythropoietin, epoetin beta, in hematologic malignancies
A Österborg et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Effect of prevention strategies on survival and quality-adjusted survival of women with BRCA1/2 mutations: An updated decision analysis
VR Grann et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Costeffectiveness of diagnostic tests
AI Mushlin et al.
LANCET (2001)
Measuring women's preferences for breast cancer treatments and BRCA1/BRCA2 testing
M Cappelli et al.
QUALITY OF LIFE RESEARCH (2001)
Use of conjoint analysis to elicit willingness-to-pay values -: Proceed with caution?
J Ratcliffe
INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE (2000)
Patient, physician, and payer perceptions and misperceptions of willingness to pay for diagnostic certainty
RA Hirth et al.
INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE (2000)
Share Paper
